F.D.A. Steps Up Oversight of Infusion Pumps


The New York Times reports the Food and Drug Administration plans to “tighten their oversight” of medical devices, including infusion pumps that automatically deliver drugs and food to hospital patients. Last week the FDA issued guidelines requiring manufacturers of the pumps to provide the agency with more test data than previously required for approval. One reason for this action is that the FDA has received reports over the past five years of 710 patient deaths, and some officials suspect the actual number may be far higher.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robert Kraft, Kraft & Associates | Attorney Advertising

Written by:


Kraft & Associates on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.